Rx News Connection: August 2023
In the medical arena, information changes quickly. What was irrelevant yesterday, may be paramount today. PharmCon’s News Connection series seeks to distill the most impactful news for health professionals from the vast sea of news that confronts us all, then bridge the gap between the immediacy of those critical items and the delay that occurs as that information is incorporated into more focused programming. Our team of skilled editors continually scans the emerging medical news to bring the most relevant pieces to the forefront and deliver them to you in a concise, practical manner. In this session, we investigate timely items, including: First Over the Counter Birth Control FDA Approved, Daily Oral Semaglutide for Obesity, First FDA-Approved OTC Product for Erectile Dysfunction, Promising Obesity Drug in Phase 2 Trials, Low-Dose Colchicine for Broad Cardiovascular Indication, and CDC Recommends RSV Vaccine for Older Adults.